Lina Quteineh

Summary

Publications

  1. ncbi Impact of VKORC1 haplotypes on long-term graft function in kidney transplantation
    Lina Quteineh
    Pharmacology Department, Pierre and Marie Curie University, Saint Antoine University Hospital, Paris, France
    Transplantation 86:779-83. 2008
  2. ncbi Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients
    Lina Quteineh
    Pharmacology Department, Pierre et Marie Curie University, Saint Antoine University Hospital, Paris, France
    Basic Clin Pharmacol Toxicol 103:546-52. 2008
  3. ncbi SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients
    Hugues Michelon
    Pharmacology Department, Univ Paris Sud, Bicetre University Hospital, Le Kremlin, Bicetre, France
    Pharmacogenomics 11:1703-13. 2010
  4. ncbi Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose
    Lina Quteineh
    Thromb Haemost 94:690-1. 2005

Collaborators

Detail Information

Publications4

  1. ncbi Impact of VKORC1 haplotypes on long-term graft function in kidney transplantation
    Lina Quteineh
    Pharmacology Department, Pierre and Marie Curie University, Saint Antoine University Hospital, Paris, France
    Transplantation 86:779-83. 2008
    ..We aimed to study the effect of VKORC1 haplotypes on long-term graft function in a cohort of kidney transplant recipients...
  2. ncbi Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients
    Lina Quteineh
    Pharmacology Department, Pierre et Marie Curie University, Saint Antoine University Hospital, Paris, France
    Basic Clin Pharmacol Toxicol 103:546-52. 2008
    ..Screening for this single nucleotide polymorphism before the transplantation might be helpful for the selection of adequate initial daily dose and to achieve the desired immunosuppression...
  3. ncbi SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients
    Hugues Michelon
    Pharmacology Department, Univ Paris Sud, Bicetre University Hospital, Le Kremlin, Bicetre, France
    Pharmacogenomics 11:1703-13. 2010
    ..This study aimed to determine the influence of gene candidates on mycophenolic acid (MPA) response during the first year of renal transplantation...
  4. ncbi Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose
    Lina Quteineh
    Thromb Haemost 94:690-1. 2005